15 Interstitial Lung Disease Clinical Trials in Atlanta, GA (2026)

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Recruiting Interstitial Lung Disease Studies in Atlanta

NCT04604418Recruiting

Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures

The incidence of moderate to severe congenital heart disease (CHD) in the United States is estimated to be 6 per 1000 live-born full term infants. Recent advances in pediatric cardiology, surgery and ...

Atlanta, GA10,000 participantsBoston Children's Hospital

View Study Details

NCT01915511Recruiting

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the registry expanded to inc...

Atlanta, GA3,000 participantsDuke University

View Study Details

NCT07132411Recruiting

Talk With Me Baby: Leveraging Well-Child Care to Enhance the Early Home Language Environment

Language-rich interactions with a parent or caregiver can serve as a protective factor for young children, by supporting their language development and other positive long-term outcomes, but existing ...

Atlanta, GA400 participantsUniversity of Kansas Medical Center

View Study Details

NCT04571658Recruiting

NEPTUNE Match Study

NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physic...

Atlanta, GA375 participantsUniversity of Michigan

View Study Details

NCT06951217Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01. Eligible participants ...

Atlanta, GA340 participantsAvalyn Pharma Inc.

View Study Details

NCT05000632Recruiting

Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families

Smoke Free SafeCare (SFSC) is a proposed braided intervention consisting of two evidence-based interventions: Some Things are Better Outside (STBO), aimed at promoting smoke free home rules, and SafeC...

Atlanta, GA268 participantsGeorgia State University

View Study Details

NCT06967805Recruiting

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)...

Atlanta, GA164 participantsMediar Therapeutics

View Study Details

NCT06672549Recruiting

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesi...

Atlanta, GA125 participantsEli Lilly and Company

View Study Details

NCT07296133Recruiting

GAMES Intervention in MCI (Mild Cognitive Impairment)

The objective of the present study is to evaluate whether online, remote gameplay can facilitate social engagement and reduce feelings of loneliness and isolation in adults with and without mild cogni...

Atlanta, GA124 participantsEmory University

View Study Details

NCT05999994Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under th...

Atlanta, GA105 participantsEli Lilly and Company

View Study Details

NCT06894979Recruiting

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

This phase I clinical trial studies the side effects and best dose of AZD1390 and to see how well it works when given together with radiation therapy for the treatment of pediatric patients with high ...

Atlanta, GA54 participantsChildren's Oncology Group

View Study Details

NCT06247787Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

This phase I trial tests the safety, side effects, and best dose of imetelstat in combination with fludarabine and cytarabine in treating patients with acute myeloid leukemia (AML), myelodysplastic sy...

Atlanta, GA36 participantsChildren's Oncology Group

View Study Details

NCT06734793Recruiting

Wearable Electronic Breath Sound Sensing Device

This study will assess the ability of a wearable stethoscope to monitor wheezing in high-risk asthma patients admitted at Children's Healthcare of Atlanta. This study is important to assist in the he...

Atlanta, GA25 participantsEmory University

View Study Details

NCT06982261Recruiting

Voice Technology-Based Self-Management Intervention

This study aims to test a new technology-based program designed to help improve the ability to manage chronic conditions. This program includes daily smart speaker use for managing different tasks an...

Atlanta, GA20 participantsEmory University

View Study Details

NCT07148258Recruiting

Evaluating Georgia Part C Implementation Outcomes

This study aims to answer the question: What is the best way to help Early Intervention (EI) providers deliver high-quality services to children with communication delays for autism? The primary goal...

Atlanta, GA20 participantsEmory University

View Study Details

About Interstitial Lung Disease Clinical Trials in Atlanta

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 15 interstitial lung disease clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 15,056 participants. Research is being sponsored by Boston Children's Hospital, Duke University, University of Kansas Medical Center and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Atlanta — FAQ

Are there interstitial lung disease clinical trials in Atlanta?

Yes, there are 15 interstitial lung disease clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 15 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 13, 2026 from ClinicalTrials.gov